LRRK2 and Parkinson disease: Although LRRK2 mutations modulate systemic glucose homeostasis and metabolic dysfunction precedes Parkinson's disease (PD) motor symptoms; the way in which pathogenic variants of LRRK2 disrupt astrocytic glucose metabolism and organellar homeostasis remains poorly understood.